Advanced search
Publication Cover
Leukemia & Lymphoma Volume 38, 2000 - Issue 1-2
Submit an article Journal homepage
35
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Successful Treatment of All-Trans Retinoic Acid Resistant and Chemotherapy Naive Acute Promyelocytic Patients with Arsenic Trioxid-e - Two Case Reports

Che-Pin Lin Institution: Department of Hemato-Oncology, Taipei Municipal Jen-Ai Hospital, No. 10 Sec. 4 Jen-Ai Road, 106, Taipei, Taiwan, ROC
,
Ming-Jer Huang Institution: Department of Hemato-Oncology, Taipei Municipal Jen-Ai Hospital, No. 10 Sec. 4 Jen-Ai Road, 106, Taipei, Taiwan, ROCCorrespondence[email protected]
,
Ian Y. Chang Institution: Department of Hemato-Oncology, Taipei Municipal Jen-Ai Hospital, No. 10 Sec. 4 Jen-Ai Road, 106, Taipei, Taiwan, ROC
&
Wen Yen Lin Institution: Department of Hemato-Oncology, Taipei Municipal Jen-Ai Hospital, No. 10 Sec. 4 Jen-Ai Road, 106, Taipei, Taiwan, ROC
Pages 191-194 | Accepted 20 Nov 1999, Published online: 01 Jul 2009

References

  • Chen G. Q., Zhu J., Shi X. G., Ni J. H., Zhong H. J., Si G. Y., Jin X. L., Tang W., Li X. S., Xong S. M., Shen Z. X., Sun G. L., Ma J., Zhang T. D., Gazin C., Naoe T., Chen S. J., Wang Z. Y., Chen Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: induces NB4 cell apoptosis with down regulation of bcl-2 expression and modulation of PML-RARaPML protein. Blood 1996; 88: 1052–8
  • Wang Z. G., Rivi R., Delva L., Konig A., Lai L., Schein-berg D., Gambacorti- Passerini Gabrilove J. L., Gabrilove J. L., Warrell R. P., Pandolfi P. P. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood 1998; 92: 1497–504
  • Zhang P., Wang S. Y., Hu X. H., Shi E. D., Qiu F. Q., Hong G. J., Han X. Y., Yang H. F., Sun Y. Z., Liu Y. P., Zhao J., Jin Z. J. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chinese Journal of Hematology 1996; 17: 58–60
  • Shen Z. X., Chen G. Q., Ni J. H., Li X. S., Xiong S. M., Qiu Q. Y., Zhu J., Tang W., Sun G. L., Yang K. Q., Chen Y., Zhou L., Fang Z. W., Wang Y. T., Ma J., Zhang P., Zhang T. D., Chen S. J., Chen Z., Wang Z. Y. Use of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL): II. Clinical efficacy and phamacokinetics in relapsed patient. Blood 1997; 89: 3354–60
  • Soignet S. L., Maslak P., Wang Z. G., Jhanwar S., Calleja E., Dardashti L. J., Corso D., DeBlasio A., Gabrilove J. J., Scheinberg D. A., Pandolfi P. P., Warrell R. P., Jr. Completet remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New England Journal of Medicine 1998; 339: 1341–8
  • Huang S. Y., Chang C. S., Tang J. L., Tien H. F., Kuo T. L., Huang S. F., Yao Y. T., Chou W. H., Chung C. Y., Wang C. H., Shen M. G., Chen Y. C. Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukemia. British Journal of Haematology 1998; 103: 1092–5
  • Lin C. P., Huang M. J., Liu H. J., Chang I. Y., Tsai H. C. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's witness with all-trans retinoic acid, rhG-CSF and erythropoietin. American Journal of Hematology 1996; 51: 251–2
  • Kanamaru A., Takemoto Y., Murakami H., Asou N., Kobayashi T., Kuriyama K., Ohmoto E., Sakamaki H., Tsubaki K. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995; 85: 1202–6
  • Gianni M., Koken M. H., Chelbi-Alix M. K., Benoit G., Lanotte M., Chen 2. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. Blood 1998; 91: 4300–110
  • Lallemand-Bretenbach V., Guillemin M. C., Janin A., Daniel M. T., Degos L., Kogan S. C., Bishop J. M., de The H. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. Journal of Experimental Medicine 1999; 189: 1043–1052

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.